Forte Biosciences, Inc.
FBRX
$18.31
-$0.78-4.09%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.68M | -11.25M | -15.66M | -7.16M | -8.39M |
| Total Depreciation and Amortization | 17.00K | 15.00K | 13.00K | 10.00K | 10.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.47M | 1.50M | 1.38M | 541.00K | 800.00K |
| Change in Net Operating Assets | 2.19M | -322.00K | 3.91M | -3.41M | -551.00K |
| Cash from Operations | -14.00M | -10.06M | -10.36M | -10.01M | -8.13M |
| Capital Expenditure | -55.00K | 0.00 | -61.00K | -31.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 36.35M | -35.96M | -- |
| Cash from Investing | -55.00K | 0.00 | 36.29M | -35.99M | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.81M | 75.00M | 9.00K | 53.00M | 6.00K |
| Repurchase of Common Stock | -5.00K | -3.00K | -15.00K | -2.00K | -7.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -475.00K | -4.65M | -2.32M | -1.12M | -1.00K |
| Cash from Financing | 1.33M | 70.35M | -2.32M | 51.88M | -2.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.73M | 60.29M | 23.61M | 5.88M | -8.14M |